SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3157Peddle your BS elsewhere. REGN's IP did not originate in universities. I neA.J. Mullen-11/8/2020
3156My first post on this thread, to which you replied, was not at all sarcastic - jA.J. Mullen-11/8/2020
3155Peddle your BS elsewhere. REGN's IP did not originate in universities. TherCuttingEdge Bio-11/8/2020
3154Sickening Bullsh!t from the Stat news insurance lobby shills. There are no marcCuttingEdge Bio-11/8/2020
3153Your note was "sarcastic",....I thought Y are expecting Gov to force *Miljenko Zuanic-11/8/2020
3152Maybe the difference is that the $450m was for production rather than science?A.J. Mullen-11/8/2020
3151First, $450m is not free. It seems the government had less expectations than wiA.J. Mullen-11/8/2020
3150I should have used a sarcastic font. I’m guessing they will come out with prBiotechwantabe111/7/2020
3149They cleared (and dedicated) NY-manuf. facility only for COVID-19. What did Gov.Miljenko Zuanic111/7/2020
3148Pharmaceuticals are only sold on an open market when the IP is exhausted. The BA.J. Mullen-11/7/2020
3147Sounds reasonable. Let regeneron sell them in an open market. States and counBiotechwantabe-11/7/2020
3146Allegations that REGN got unusally favorable terms from the government in its $4A.J. Mullen-11/6/2020
3145Any guesstimate on 2021 prod revenue Dupi 4b +50% +2 Eylea and other +1 Cov2 +Biotechwantabe-11/6/2020
3144< Hopefully manufacturing goes better than expected.> In last 10 Y REGN iMiljenko Zuanic-11/6/2020
3143Roche deal was a good way to increase supply; plus regeneron increasing capacityBiotechwantabe-11/5/2020
3142<Row 780m +7(bayer is a lazy partner)> I do not agree. It is ar 4Q-19 levMiljenko Zuanic-11/5/2020
3141On partnership and row sales: Eylea US 1318m +11% Row 780m +7(bayer is a lazyBiotechwantabe-11/5/2020
3140It’ll take a few years. Missing the cov2 window. Ready for next opportunity? Biotechwantabe-11/5/2020
3139<Not until they increase US manufacturing volume limitations.> And what YMiljenko Zuanic-11/5/2020
3138The dilemma: Works best administered early. Works best on seronegative. For ouBiotechwantabe-11/4/2020
3137I believe it took 6 weeks to approve remdisivir. I’d be disappointed it it it Biotechwantabe-11/4/2020
3136Why next week for EUA? Regardless, I don't see a big spike in SP given theyFelix B-11/4/2020
3135Looks like mr. market is more concerned about election results than buying good Biotechwantabe-11/4/2020
3134REGN-COV2 Oct 31 presentation Biotechwantabe-11/3/2020
3133REGN-COV2 INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS HOLDING ENROLLMENT INBiotechwantabe-10/30/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News